Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$66,727,273
+$25,545,451 QoQ
Shares Held
581,907
+17.7% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. KYMR ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,727,273 | 581,907 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $41,181,822 | 494,439 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $36,338,979 | 467,022 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $24,740,990 | 437,120 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $17,864,163 | 409,353 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $11,540,831 | 421,660 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $17,614,019 | 437,833 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $18,183,002 | 384,175 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $10,989,007 | 368,141 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $14,985,994 | 372,786 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,129,420 | 358,579 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,090,943 | 366,255 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,159,793 | 354,928 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,980,182 | 336,827 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,522,365 | 341,441 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,221,934 | 331,738 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,564,211 | 333,378 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,536,897 | 319,870 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $21,516,758 | 338,900 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $19,896,588 | 338,723 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,586,476 | 259,515 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $4,566,088 | 117,501 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,559,412 | 121,926 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||